Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention
John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital), Alice Cheng(Morristown Medical Center), Brendon L. Neuen(The George Institute for Global Health), Adam J. Nelson(Clinical Research Institute), Naveed Sattar(University of Glasgow)
Cited by 15
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k